Friday, December 5, 2025
Search

Afya And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Via News Editorial Team

October 15, 2022

Afya  And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Afya (AFYA), AGCO (AGCO), Balchem Corporation (BCPC) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Afya (AFYA)

36.8% sales growth and 8.78% return on equity

Through its subsidiaries, Afya Limited operates in Brazil as a medical education organization. The company offers educational products, such as medical schools, residency preparation courses, graduate courses and other programs, to both lifelong learners and third-party schools. It also offers digital health services such as a subscription-based app and portal. These tools are designed to assist students and health professionals with their clinical decision-making. The company offers courses in health sciences, such as medicine, nursing, radiology and psychology. It also provides courses in pedagogy, business administration and accounting. The company also offers medical postgraduate specializations, printed and digital content, and an online platform for medical education and services in practical medicine training. It had 46 undergrad and graduate schools, five operating units, and five authorized units. There were also 2,731 seats in its network. This network consisted of 2481 approved seats and 278 operating seats. Nova Lima is the headquarters of this company, which was established in 1999.

Earnings Per Share

As for profitability, Afya has a trailing twelve months EPS of $0.44.

PE Ratio

Afya has a trailing twelve months price to earnings ratio of 30.21. Meaning, the purchaser of the share is investing $30.21 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.78%.

2. AGCO (AGCO)

15.1% sales growth and 23.83% return on equity

AGCO Corporation is a distributor of agricultural equipment worldwide. AGCO Corporation manufactures and distributes agricultural equipment and related replacement parts worldwide. It has horsepower tractors that can be used for row crop cultivation, soil cultivation and planting. It also offers grain storage containers and associated drying and handling equipment systems, seed-processing system and seed-processing equipment delivery systems. Ventilation and watering systems are available. Egg production systems as well as broiler production equipment and equipment. It also offers rectangular and round balers as well as self-propelled windrowers and loader wagons. The company also offers implements such as disc harrows that level seedbeds and add chemicals to the soils. It also provides heavy tillage which breaks up the soil and mixes crop residue with topsoil. Field cultivators are used for preparing smooth seed beds and removing weeds. Drills can be purchased for small-grain seeding. It also offers combine harvesters for corn, wheat and soybeans; as well as application equipment such as self-propelled three- or four-wheeled vehicles and other equipment for liquid fertilizers and crop protection chemicals. Through a network independent distributors and dealers, the company sells its products under Challenger, Fendt and GSI brands. AGCO Corporation was established in 1990. It is located in Duluth in Georgia.

Earnings Per Share

As for profitability, AGCO has a trailing twelve months EPS of $6.8.

PE Ratio

AGCO has a trailing twelve months price to earnings ratio of 15.88. Meaning, the purchaser of the share is investing $15.88 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.83%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Aug 11, 2022, the estimated forward annual dividend rate is 0.96 and the estimated forward annual dividend yield is 0.88%.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is 41.1% and 25.6%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.3%, now sitting on 11.51B for the twelve trailing months.

Volume

Today's last reported volume for AGCO is 370506 which is 36.65% below its average volume of 584879.

3. Balchem Corporation (BCPC)

14.6% sales growth and 12.27% return on equity

Balchem Corporation designs, produces, markets and distributes specialty performance ingredients for the food, pharmaceutical and animal health markets. The company operates in three main segments, Human Nutrition & Health and Animal Nutrition & Health. Specialty Products is also part of its business. Human Nutrition & Health supplies ingredients for the food- and beverage industries. Products include extrusion, agglomeration and blended lipid systems. They also offer liquid flavor delivery systems and juice and dairy bases. The segment offers microencapsulation and high-quality choline nutrition and minerals amino acid chelated products. These are ideal for wellness applications. Animal Nutrition & Health offers microencapsulated products that enhance ruminant health, milk production, and chelation technology which provides enhanced nutrient absorption to various production species and companion animals. Choline chloride is a nutrient essential for monogastric animals' health. Specialty Products offers ethylene dioxide primarily for the healthcare industry. Single-use canisters with Ethylene oxide are also available for sterilizing re-usable items. Propylene oxide is also sold in this segment. This fumigant helps in controlling insects, microbiological spoilage and reduces bacterial and mold contamination in processed nuts, shells and spices. It sells products via sales representatives, independent distributors and agents. Balchem Corporation was founded in 1967. It is located in New Hampton in New York.

Earnings Per Share

As for profitability, Balchem Corporation has a trailing twelve months EPS of $3.34.

PE Ratio

Balchem Corporation has a trailing twelve months price to earnings ratio of 37.73. Meaning, the purchaser of the share is investing $37.73 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.27%.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is 3.3% and 8.2%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Balchem Corporation's EBITDA is 81.32.

4. Charles River Laboratories (CRL)

12.9% sales growth and 17.6% return on equity

Charles River Laboratories International, Inc. is a nonclinical contract research organisation that provides safety testing, drug discovery, and non-clinical development services throughout the United States, Europe, Canada, Asia Pacific, as well as internationally. The company operates in three distinct segments: Research Models and Services, Discovery and Safety Assessments (DSA), and Manufacturing Solutions. RMS sells research rodent model strains, purpose-bred mice and rats for researchers. The segment offers a variety of services that assist clients with the support of research models for screening and testing non-clinical drugs candidates. This includes research models, genetically engineered model and service, insourcing solutions and animal diagnostics services. DSA offers in-vivo and early discovery services to identify and validate novel targets, chemical compounds and antibodies. It also delivers non-clinical therapeutic and drug candidates for safety assessment. Safety assessment services include toxicology and pathology. In vitro testing methods are available for non-sterile, sterile pharmaceuticals as well as consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. It also offers contract vivarium operations services for biopharmaceutical customers. Charles River Laboratories International, Inc., was established in 1947. It is located in Wilmington, Massachusetts.

Earnings Per Share

As for profitability, Charles River Laboratories has a trailing twelve months EPS of $7.2.

PE Ratio

Charles River Laboratories has a trailing twelve months price to earnings ratio of 27.48. Meaning, the purchaser of the share is investing $27.48 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.6%.

5. Dominion Resources (D)

7.9% sales growth and 8.74% return on equity

Dominion Energy, Inc. distributes and produces energy throughout the United States. There are four main segments of the company: Dominion Energy Virginia; Gas Distribution, Dominion Energy South Carolina; and Contracted Assets. Dominion Energy Virginia generates, transmits and distributes electricity to about 2.7 million residents, businesses, industrial, and government customers in Virginia, North Carolina. Gas Distribution is responsible for the regulation of natural gas sales and transportation. It also gathers, stores, transports, collects, stores, and distributes it in Ohio, West Virginia and North Carolina. This segment serves approximately 3.1 Million residential, commercial, and industrial customers. There are also non-regulated, renewable natural gas plants in operation. Dominion Energy South Carolina generates, transmits and distributes electricity in approximately 772,000 South Carolina customers. It also distributes natural gas in approximately 419,000 South Carolina residential, commercial and industrial customers. Contracted Assets is responsible for long-term, nonregulated contracts in renewable electricity generation, solar generator facility development, gas transportation, LNG import and storage, and the liquefaction plant. The company had approximately 30.2-gigawatts of electrical generating capacity, 10,700 miles worth of electric transmission lines, 78,000 miles worth of electric distribution lines, and 95.700 miles worth of gas distribution mains. The former name of the company was Dominion Resources, Inc. Dominion Energy, Inc. is located in Richmond, Virginia.

Earnings Per Share

As for profitability, Dominion Resources has a trailing twelve months EPS of $-0.57.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.74%.

Moving Average

Dominion Resources's worth is way below its 50-day moving average of $80.19 and way below its 200-day moving average of $80.77.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 14.37B for the twelve trailing months.